Kennedy Medical Group
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Cyclobenzaprine Hydrochloride Extended Release for the Treatment of Chronic Migraine (NCT01151787) | Kennedy Medical Group | 2010-07-01 |
Track Kennedy Medical Group automatically
Every clearance here is in the API, with alerts when new ones post.